|
| 36563336 | Flotetuzumab and other T-cell immunotherapies upregulate MHC class II expression on acute myeloid leukemia cells. | Blood | 2023 |
| 38023733 | Single-cell transcriptomics reveals long noncoding RNAs associated with tumor biology and the microenvironment in pancreatic cancer. | NAR Cancer | 2023 |
| 37744381 | Baricitinib with cyclosporine eliminates acute graft rejection in fully mismatched skin and heart transplant models. | Front Immunol | 2023 |
| 37914932 | Epigenetic regulation during cancer transitions across 11 tumour types. | Nature | 2023 |
| 37961519 | Differential chromatin accessibility and transcriptional dynamics define breast cancer subtypes and their lineages. | bioRxiv | 2023 |
| 36973268 | Epigenetic and transcriptomic characterization reveals progression markers and essential pathways in clear cell renal cell carcinoma. | Nat Commun | 2023 |
| 36779841 | Single-Cell Discovery and Multiomic Characterization of Therapeutic Targets in Multiple Myeloma. | Cancer Res | 2023 |
| 36702834 | Cross center single-cell RNA sequencing study of the immune microenvironment in rapid progressing multiple myeloma. | NPJ Genom Med | 2023 |
| 37198186 | Author Correction: Epigenetic and transcriptomic characterization reveals progression markers and essential pathways in clear cell renal cell carcinoma. | Nat Commun | 2023 |
| 37069359 | Motixafortide and G-CSF to mobilize hematopoietic stem cells for autologous transplantation in multiple myeloma: a randomized phase 3 trial. | Nat Med | 2023 |
| 36563336 | Flotetuzumab and other T-cell immunotherapies upregulate MHC class II expression on acute myeloid leukemia cells. | Blood | 2023 |
| 38023733 | Single-cell transcriptomics reveals long noncoding RNAs associated with tumor biology and the microenvironment in pancreatic cancer. | NAR Cancer | 2023 |
| 37914932 | Epigenetic regulation during cancer transitions across 11 tumour types. | Nature | 2023 |
| 37961519 | Differential chromatin accessibility and transcriptional dynamics define breast cancer subtypes and their lineages. | bioRxiv | 2023 |
| 37744381 | Baricitinib with cyclosporine eliminates acute graft rejection in fully mismatched skin and heart transplant models. | Front Immunol | 2023 |
| 36973268 | Epigenetic and transcriptomic characterization reveals progression markers and essential pathways in clear cell renal cell carcinoma. | Nat Commun | 2023 |
| 37069359 | Motixafortide and G-CSF to mobilize hematopoietic stem cells for autologous transplantation in multiple myeloma: a randomized phase 3 trial. | Nat Med | 2023 |
| 37198186 | Author Correction: Epigenetic and transcriptomic characterization reveals progression markers and essential pathways in clear cell renal cell carcinoma. | Nat Commun | 2023 |
| 36779841 | Single-Cell Discovery and Multiomic Characterization of Therapeutic Targets in Multiple Myeloma. | Cancer Res | 2023 |
| 36702834 | Cross center single-cell RNA sequencing study of the immune microenvironment in rapid progressing multiple myeloma. | NPJ Genom Med | 2023 |
| 34996889 | Author Correction: Comprehensive characterization of 536 patient-derived xenograft models prioritizes candidates for targeted treatment. | Nat Commun | 2022 |
| 35697686 | A long-acting interleukin-7, rhIL-7-hyFc, enhances CAR T cell expansion, persistence, and anti-tumor activity. | Nat Commun | 2022 |
| 35422095 | CS1 CAR-T targeting the distal domain of CS1 (SLAMF7) shows efficacy in high tumor burden myeloma model despite fratricide of CD8+CS1 expressing CAR-T cells. | Leukemia | 2022 |
| 35995947 | Spatially restricted drivers and transitional cell populations cooperate with the microenvironment in untreated and chemo-resistant pancreatic cancer. | Nat Genet | 2022 |
| 35418131 | LINC00355 regulates p27<sup>KIP</sup> expression by binding to MENIN to induce proliferation in late-stage relapse breast cancer. | NPJ Breast Cancer | 2022 |
| 35603231 | Pollock: fishing for cell states. | Bioinform Adv | 2022 |
| 36969740 | Comprehensive Characterization of the Multiple Myeloma Immune Microenvironment Using Integrated scRNA-seq, CyTOF, and CITE-seq Analysis. | Cancer Res Commun | 2022 |
| 34996889 | Author Correction: Comprehensive characterization of 536 patient-derived xenograft models prioritizes candidates for targeted treatment. | Nat Commun | 2022 |
| 35697686 | A long-acting interleukin-7, rhIL-7-hyFc, enhances CAR T cell expansion, persistence, and anti-tumor activity. | Nat Commun | 2022 |
| 35603231 | Pollock: fishing for cell states. | Bioinform Adv | 2022 |
| 35422095 | CS1 CAR-T targeting the distal domain of CS1 (SLAMF7) shows efficacy in high tumor burden myeloma model despite fratricide of CD8+CS1 expressing CAR-T cells. | Leukemia | 2022 |
| 35418131 | LINC00355 regulates p27<sup>KIP</sup> expression by binding to MENIN to induce proliferation in late-stage relapse breast cancer. | NPJ Breast Cancer | 2022 |
| 36969740 | Comprehensive Characterization of the Multiple Myeloma Immune Microenvironment Using Integrated scRNA-seq, CyTOF, and CITE-seq Analysis. | Cancer Res Commun | 2022 |
| 35995947 | Spatially restricted drivers and transitional cell populations cooperate with the microenvironment in untreated and chemo-resistant pancreatic cancer. | Nat Genet | 2022 |
| 33963182 | Co-evolution of tumor and immune cells during progression of multiple myeloma. | Nat Commun | 2021 |
| 33963182 | Co-evolution of tumor and immune cells during progression of multiple myeloma. | Nat Commun | 2021 |
| 34429404 | Comprehensive characterization of 536 patient-derived xenograft models prioritizes candidatesfor targeted treatment. | Nat Commun | 2021 |
| 34429404 | Comprehensive characterization of 536 patient-derived xenograft models prioritizes candidatesfor targeted treatment. | Nat Commun | 2021 |
| 32471990 | Evolution and structure of clinically relevant gene fusions in multiple myeloma. | Nat Commun | 2020 |
| 32471990 | Evolution and structure of clinically relevant gene fusions in multiple myeloma. | Nat Commun | 2020 |
| 33149122 | Discovery of driver non-coding splice-site-creating mutations in cancer. | Nat Commun | 2020 |
| 33149122 | Discovery of driver non-coding splice-site-creating mutations in cancer. | Nat Commun | 2020 |
| 32642734 | Whole exome sequencing reveals the maintained polyclonal nature from primary to metastatic malignant peripheral nerve sheath tumor in two patients with NF1. | Neurooncol Adv | 2019 |
| 32642734 | Whole exome sequencing reveals the maintained polyclonal nature from primary to metastatic malignant peripheral nerve sheath tumor in two patients with NF1. | Neurooncol Adv | 2019 |
| 29625049 | Perspective on Oncogenic Processes at the End of the Beginning of Cancer Genomics. | Cell | 2018 |
| 29625052 | Pathogenic Germline Variants in 10,389 Adult Cancers. | Cell | 2018 |
| 29625049 | Perspective on Oncogenic Processes at the End of the Beginning of Cancer Genomics. | Cell | 2018 |
| 29617666 | Systematic Analysis of Splice-Site-Creating Mutations in Cancer. | Cell Rep | 2018 |
| 29617662 | Driver Fusions and Their Implications in the Development and Treatment of Human Cancers. | Cell Rep | 2018 |
| 29617666 | Systematic Analysis of Splice-Site-Creating Mutations in Cancer. | Cell Rep | 2018 |